HEADER PENICILLIN-BINDING PROTEIN/INHIBITOR 10-SEP-14 4WEK TITLE CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA PBP3 WITH A R4 SUBSTITUTED TITLE 2 VINYL MONOCARBAM COMPND MOL_ID: 1; COMPND 2 MOLECULE: PENICILLIN-BINDING PROTEIN 3; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA ATCC 14886; SOURCE 3 ORGANISM_TAXID: 1163392; SOURCE 4 GENE: FTSI, PABE171_4609; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, SIDEROPHORE-CONJUGATED MONOCARBAMS, PSEUDOMONAS KEYWDS 2 AERUGINOSA, PENICILLIN-BINDING PROTEIN 3, PENICILLIN-BINDING KEYWDS 3 PROTEIN-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.D.FERGUSON REVDAT 4 16-OCT-24 4WEK 1 REMARK REVDAT 3 27-SEP-23 4WEK 1 SOURCE REMARK REVDAT 2 10-JUN-15 4WEK 1 JRNL REVDAT 1 22-APR-15 4WEK 0 JRNL AUTH K.E.MURPHY-BENENATO,B.DANGEL,H.E.DAVIS,T.F.DURAND-REVILLE, JRNL AUTH 2 A.D.FERGUSON,N.GAO,H.JAHIC,J.P.MUELLER,E.L.MANYAK,O.QUIROGA, JRNL AUTH 3 M.ROONEY,L.SHA,M.SYLVESTER,F.WU,M.ZAMBROWSKI,S.X.ZHAO JRNL TITL SAR AND STRUCTURAL ANALYSIS OF SIDEROPHORE-CONJUGATED JRNL TITL 2 MONOCARBAM INHIBITORS OF PSEUDOMONAS AERUGINOSA PBP3. JRNL REF ACS MED.CHEM.LETT. V. 6 537 2015 JRNL REFN ISSN 1948-5875 JRNL PMID 26005529 JRNL DOI 10.1021/ACSMEDCHEMLETT.5B00026 REMARK 2 REMARK 2 RESOLUTION. 1.74 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.74 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 54299 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.207 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 2755 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.73 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.77 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.34 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3695 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2133 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3514 REMARK 3 BIN R VALUE (WORKING SET) : 0.2130 REMARK 3 BIN FREE R VALUE : 0.2187 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 181 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3820 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 308 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.48 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.89990 REMARK 3 B22 (A**2) : -0.61510 REMARK 3 B33 (A**2) : 7.51490 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.210 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.111 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.101 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.107 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.100 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3962 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5384 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1384 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 91 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 598 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3962 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 509 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : 2 ; 1.000 ; HARMONIC REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4922 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.03 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.50 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.12 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 5.5827 19.8750 -1.4889 REMARK 3 T TENSOR REMARK 3 T11: -0.0888 T22: -0.0628 REMARK 3 T33: -0.0737 T12: -0.0129 REMARK 3 T13: 0.0129 T23: 0.0137 REMARK 3 L TENSOR REMARK 3 L11: 0.0000 L22: 0.3738 REMARK 3 L33: 1.3689 L12: -0.1549 REMARK 3 L13: -0.1849 L23: 0.4973 REMARK 3 S TENSOR REMARK 3 S11: 0.0141 S12: 0.0355 S13: 0.0236 REMARK 3 S21: -0.0627 S22: 0.0595 S23: -0.0121 REMARK 3 S31: -0.1182 S32: 0.0621 S33: -0.0736 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4WEK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-SEP-14. REMARK 100 THE DEPOSITION ID IS D_1000203670. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 54364 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.739 REMARK 200 RESOLUTION RANGE LOW (A) : 89.896 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 8.000 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.73 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 8.00 REMARK 200 R MERGE FOR SHELL (I) : 0.60600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3PBO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 4000, 0.2M MGCL2, 0.1M TRIS PH REMARK 280 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.46200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.94800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.61600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.94800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.46200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.61600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 286 REMARK 465 GLY A 287 REMARK 465 HIS A 288 REMARK 465 HIS A 289 REMARK 465 HIS A 290 REMARK 465 HIS A 291 REMARK 465 HIS A 292 REMARK 465 HIS A 293 REMARK 465 SER A 294 REMARK 465 VAL A 735 REMARK 465 SER A 736 REMARK 465 VAL A 737 REMARK 465 GLY A 738 REMARK 465 THR A 739 REMARK 465 LYS A 740 REMARK 465 GLY A 741 REMARK 465 TYR A 742 REMARK 465 ARG A 743 REMARK 465 GLU A 744 REMARK 465 PRO A 805 REMARK 465 THR A 806 REMARK 465 ALA A 807 REMARK 465 THR A 808 REMARK 465 GLU A 809 REMARK 465 GLN A 810 REMARK 465 GLN A 811 REMARK 465 GLN A 812 REMARK 465 VAL A 813 REMARK 465 ASN A 814 REMARK 465 ALA A 815 REMARK 465 ALA A 816 REMARK 465 PRO A 817 REMARK 465 ALA A 818 REMARK 465 LYS A 819 REMARK 465 GLY A 820 REMARK 465 GLY A 821 REMARK 465 ARG A 822 REMARK 465 GLY A 823 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 520 C - N - CA ANGL. DEV. = 15.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 519 77.42 51.32 REMARK 500 LEU A 520 20.10 114.06 REMARK 500 PRO A 564 30.21 -94.86 REMARK 500 ARG A 582 -91.77 -126.25 REMARK 500 ASN A 671 42.13 -83.92 REMARK 500 ASP A 759 79.65 -153.37 REMARK 500 ASN A 803 78.28 -104.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 3LC A 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4WEJ RELATED DB: PDB REMARK 900 RELATED ID: 4WEL RELATED DB: PDB DBREF 4WEK A 294 823 UNP K1C6A4 K1C6A4_PSEAI 50 579 SEQADV 4WEK MET A 286 UNP K1C6A4 INITIATING METHIONINE SEQADV 4WEK GLY A 287 UNP K1C6A4 EXPRESSION TAG SEQADV 4WEK HIS A 288 UNP K1C6A4 EXPRESSION TAG SEQADV 4WEK HIS A 289 UNP K1C6A4 EXPRESSION TAG SEQADV 4WEK HIS A 290 UNP K1C6A4 EXPRESSION TAG SEQADV 4WEK HIS A 291 UNP K1C6A4 EXPRESSION TAG SEQADV 4WEK HIS A 292 UNP K1C6A4 EXPRESSION TAG SEQADV 4WEK HIS A 293 UNP K1C6A4 EXPRESSION TAG SEQADV 4WEK SER A 294 UNP K1C6A4 ALA 50 CLONING ARTIFACT SEQRES 1 A 538 MET GLY HIS HIS HIS HIS HIS HIS SER ARG SER VAL ARG SEQRES 2 A 538 HIS ILE ALA ILE PRO ALA HIS ARG GLY LEU ILE THR ASP SEQRES 3 A 538 ARG ASN GLY GLU PRO LEU ALA VAL SER THR PRO VAL THR SEQRES 4 A 538 THR LEU TRP ALA ASN PRO LYS GLU LEU MET THR ALA LYS SEQRES 5 A 538 GLU ARG TRP PRO GLN LEU ALA ALA ALA LEU GLY GLN ASP SEQRES 6 A 538 THR LYS LEU PHE ALA ASP ARG ILE GLU GLN ASN ALA GLU SEQRES 7 A 538 ARG GLU PHE ILE TYR LEU VAL ARG GLY LEU THR PRO GLU SEQRES 8 A 538 GLN GLY GLU GLY VAL ILE ALA LEU LYS VAL PRO GLY VAL SEQRES 9 A 538 TYR SER ILE GLU GLU PHE ARG ARG PHE TYR PRO ALA GLY SEQRES 10 A 538 GLU VAL VAL ALA HIS ALA VAL GLY PHE THR ASP VAL ASP SEQRES 11 A 538 ASP ARG GLY ARG GLU GLY ILE GLU LEU ALA PHE ASP GLU SEQRES 12 A 538 TRP LEU ALA GLY VAL PRO GLY LYS ARG GLN VAL LEU LYS SEQRES 13 A 538 ASP ARG ARG GLY ARG VAL ILE LYS ASP VAL GLN VAL THR SEQRES 14 A 538 LYS ASN ALA LYS PRO GLY LYS THR LEU ALA LEU SER ILE SEQRES 15 A 538 ASP LEU ARG LEU GLN TYR LEU ALA HIS ARG GLU LEU ARG SEQRES 16 A 538 ASN ALA LEU LEU GLU ASN GLY ALA LYS ALA GLY SER LEU SEQRES 17 A 538 VAL ILE MET ASP VAL LYS THR GLY GLU ILE LEU ALA MET SEQRES 18 A 538 THR ASN GLN PRO THR TYR ASN PRO ASN ASN ARG ARG ASN SEQRES 19 A 538 LEU GLN PRO ALA ALA MET ARG ASN ARG ALA MET ILE ASP SEQRES 20 A 538 VAL PHE GLU PRO GLY SER THR VAL LYS PRO PHE SER MET SEQRES 21 A 538 SER ALA ALA LEU ALA SER GLY ARG TRP LYS PRO SER ASP SEQRES 22 A 538 ILE VAL ASP VAL TYR PRO GLY THR LEU GLN ILE GLY ARG SEQRES 23 A 538 TYR THR ILE ARG ASP VAL SER ARG ASN SER ARG GLN LEU SEQRES 24 A 538 ASP LEU THR GLY ILE LEU ILE LYS SER SER ASN VAL GLY SEQRES 25 A 538 ILE SER LYS ILE ALA PHE ASP ILE GLY ALA GLU SER ILE SEQRES 26 A 538 TYR SER VAL MET GLN GLN VAL GLY LEU GLY GLN ASP THR SEQRES 27 A 538 GLY LEU GLY PHE PRO GLY GLU ARG VAL GLY ASN LEU PRO SEQRES 28 A 538 ASN HIS ARG LYS TRP PRO LYS ALA GLU THR ALA THR LEU SEQRES 29 A 538 ALA TYR GLY TYR GLY LEU SER VAL THR ALA ILE GLN LEU SEQRES 30 A 538 ALA HIS ALA TYR ALA ALA LEU ALA ASN ASP GLY LYS SER SEQRES 31 A 538 VAL PRO LEU SER MET THR ARG VAL ASP ARG VAL PRO ASP SEQRES 32 A 538 GLY VAL GLN VAL ILE SER PRO GLU VAL ALA SER THR VAL SEQRES 33 A 538 GLN GLY MET LEU GLN GLN VAL VAL GLU ALA GLN GLY GLY SEQRES 34 A 538 VAL PHE ARG ALA GLN VAL PRO GLY TYR HIS ALA ALA GLY SEQRES 35 A 538 LYS SER GLY THR ALA ARG LYS VAL SER VAL GLY THR LYS SEQRES 36 A 538 GLY TYR ARG GLU ASN ALA TYR ARG SER LEU PHE ALA GLY SEQRES 37 A 538 PHE ALA PRO ALA THR ASP PRO ARG ILE ALA MET VAL VAL SEQRES 38 A 538 VAL ILE ASP GLU PRO SER LYS ALA GLY TYR PHE GLY GLY SEQRES 39 A 538 LEU VAL SER ALA PRO VAL PHE SER LYS VAL MET ALA GLY SEQRES 40 A 538 ALA LEU ARG LEU MET ASN VAL PRO PRO ASP ASN LEU PRO SEQRES 41 A 538 THR ALA THR GLU GLN GLN GLN VAL ASN ALA ALA PRO ALA SEQRES 42 A 538 LYS GLY GLY ARG GLY HET 3LC A 901 52 HETNAM 3LC (3S,4S,7Z)-7-(2-AMINO-1,3-THIAZOL-4-YL)-3-ETHENYL-4- HETNAM 2 3LC FORMYL-1-[({3-(5-HYDROXY-4-OXO-3,4-DIHYDROPYRIDIN-2- HETNAM 3 3LC YL)-4-[3-(METHYLSULFONYL)PROPYL]-5-OXO-4,5-DIHYDRO-1H- HETNAM 4 3LC 1,2,4-TRIAZOL-1-YL}SULFONYL)AMINO]-10,10-DIMETHYL-1,6- HETNAM 5 3LC DIOXO-9-OXA-2,5,8-TRIAZAUNDEC-7-EN-11-OIC ACID FORMUL 2 3LC C26 H32 N10 O13 S3 FORMUL 3 HOH *308(H2 O) HELIX 1 AA1 ASN A 329 MET A 334 1 6 HELIX 2 AA2 THR A 335 GLU A 338 5 4 HELIX 3 AA3 ARG A 339 LEU A 347 1 9 HELIX 4 AA4 ASP A 350 ASN A 361 1 12 HELIX 5 AA5 THR A 374 ALA A 383 1 10 HELIX 6 AA6 ALA A 401 VAL A 404 5 4 HELIX 7 AA7 VAL A 405 GLY A 410 1 6 HELIX 8 AA8 GLU A 420 PHE A 426 1 7 HELIX 9 AA9 PHE A 426 GLY A 432 1 7 HELIX 10 AB1 ASP A 468 GLY A 487 1 20 HELIX 11 AB2 GLN A 521 ARG A 526 1 6 HELIX 12 AB3 ASN A 527 ASP A 532 1 6 HELIX 13 AB4 PRO A 536 THR A 539 5 4 HELIX 14 AB5 VAL A 540 SER A 551 1 12 HELIX 15 AB6 LEU A 586 LYS A 592 1 7 HELIX 16 AB7 SER A 594 GLY A 606 1 13 HELIX 17 AB8 GLY A 606 VAL A 617 1 12 HELIX 18 AB9 PRO A 642 TYR A 651 1 10 HELIX 19 AC1 THR A 658 ASN A 671 1 14 HELIX 20 AC2 SER A 694 ALA A 711 1 18 HELIX 21 AC3 VAL A 715 GLN A 719 5 5 HELIX 22 AC4 PHE A 777 SER A 782 1 6 HELIX 23 AC5 SER A 782 MET A 797 1 16 SHEET 1 AA1 3 SER A 296 ILE A 302 0 SHEET 2 AA1 3 GLY A 435 LYS A 441 -1 O LYS A 441 N SER A 296 SHEET 3 AA1 3 VAL A 447 LYS A 455 -1 O GLN A 452 N GLN A 438 SHEET 1 AA2 3 ILE A 367 LEU A 373 0 SHEET 2 AA2 3 PRO A 316 ALA A 328 -1 N LEU A 326 O VAL A 370 SHEET 3 AA2 3 VAL A 389 PHE A 398 -1 O ILE A 392 N THR A 325 SHEET 1 AA3 4 ILE A 367 LEU A 373 0 SHEET 2 AA3 4 PRO A 316 ALA A 328 -1 N LEU A 326 O VAL A 370 SHEET 3 AA3 4 ILE A 309 THR A 310 -1 N ILE A 309 O LEU A 317 SHEET 4 AA3 4 LEU A 463 ALA A 464 1 O LEU A 463 N THR A 310 SHEET 1 AA4 5 ILE A 503 GLN A 509 0 SHEET 2 AA4 5 ALA A 490 ASP A 497 -1 N ILE A 495 O ALA A 505 SHEET 3 AA4 5 ILE A 762 ASP A 769 -1 O ALA A 763 N MET A 496 SHEET 4 AA4 5 TYR A 747 ALA A 755 -1 N SER A 749 O ILE A 768 SHEET 5 AA4 5 ALA A 726 ARG A 733 -1 N GLY A 730 O LEU A 750 SHEET 1 AA5 2 ILE A 559 ASP A 561 0 SHEET 2 AA5 2 GLN A 583 ASP A 585 -1 O LEU A 584 N VAL A 560 SHEET 1 AA6 2 THR A 566 ILE A 569 0 SHEET 2 AA6 2 TYR A 572 ARG A 575 -1 O TYR A 572 N ILE A 569 SHEET 1 AA7 2 LYS A 674 SER A 675 0 SHEET 2 AA7 2 VAL A 690 GLN A 691 -1 O VAL A 690 N SER A 675 LINK OG SER A 538 C10 3LC A 901 1555 1555 1.29 CISPEP 1 GLN A 509 PRO A 510 0 -2.56 CISPEP 2 ASN A 519 LEU A 520 0 10.32 CISPEP 3 TYR A 563 PRO A 564 0 1.43 CISPEP 4 ALA A 755 PRO A 756 0 -8.72 SITE 1 AC1 27 GLU A 535 SER A 538 VAL A 577 SER A 578 SITE 2 AC1 27 SER A 593 ASN A 595 GLY A 652 TYR A 653 SITE 3 AC1 27 GLY A 713 GLY A 714 VAL A 715 ARG A 717 SITE 4 AC1 27 LYS A 728 SER A 729 GLY A 730 THR A 731 SITE 5 AC1 27 ALA A 732 ARG A 733 TYR A 747 PHE A 777 SITE 6 AC1 27 GLY A 778 GLY A 779 HOH A1144 HOH A1171 SITE 7 AC1 27 HOH A1248 HOH A1300 HOH A1304 CRYST1 68.924 83.232 89.896 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014509 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012015 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011124 0.00000